Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/art.41285 http://scihub22266oqcxt.onion/10.1002/art.41285 32293098!7262347!32293098     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Arthritis+Rheumatol 2020 ; 72 (7): 1059-1063 Nephropedia Template TP {{tp|p=32293098|t=2020. On the Alert for Cytokine Storm: Immunopathology in COVID-19 |pdf=|usr=}}{{32293098}} gab.com Text On the Alert for Cytokine Storm: Immunopathology in COVID-19 JO: Arthritis Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=32293098 #FOAvip Poor outcomes in COVID-19 correlate with clinical and laboratory features of cytokine storm syndrome. Broad screening for cytokine storm and early, targeted antiinflammatory therapy may prevent immunopathology and could help conserve limited health care resources. While studies are ongoing, extrapolating from clinical experience in cytokine storm syndromes may benefit the multidisciplinary teams caring for patients with severe COVID-19. Twit Text FOAVip On the Alert for Cytokine Storm: Immunopathology in COVID-19 ????Arthritis Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=32293098 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32293098 #FOAvip English Wikipedia <ref>{{Cite pmid|32293098}}</ref> On the Alert for Cytokine Storm: Immunopathology in COVID-19 #MMPMID32293098 Henderson LA; Canna SW; Schulert GS; Volpi S; Lee PY; Kernan KF; Caricchio R; Mahmud S; Hazen MM; Halyabar O; Hoyt KJ; Han J; Grom AA; Gattorno M; Ravelli A; De Benedetti F; Behrens EM; Cron RQ; Nigrovic PA Arthritis Rheumatol 2020[Jul]; 72 (7): 1059-1063 PMID32293098show ga Poor outcomes in COVID-19 correlate with clinical and laboratory features of cytokine storm syndrome. Broad screening for cytokine storm and early, targeted antiinflammatory therapy may prevent immunopathology and could help conserve limited health care resources. While studies are ongoing, extrapolating from clinical experience in cytokine storm syndromes may benefit the multidisciplinary teams caring for patients with severe COVID-19. |Anti-Inflammatory Agents/*therapeutic use[MESH] |Betacoronavirus[MESH] |Biomarkers[MESH] |COVID-19[MESH] |Coronavirus Infections/complications/*immunology/therapy[MESH] |Cytokine Release Syndrome/diagnosis/*drug therapy/*virology[MESH] |Early Medical Intervention[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/*immunology/therapy[MESH]On the Alert for Cytokine Storm: Immunopathology in COVID-19 (epmc).pdf DeepDyve Pubget Overpricing